Skip to main content
Ulunar Breezhaler-H-C-3875-PSUV-0002: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Ulunar Breezhaler-H-C-3875-PSUV-0002: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

48 views
Download
Pharmaceutical

Ulunar Breezhaler-H-C-3875-PSUV-0002: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Advanced pharmaceutical formulation for targeted therapeutic intervention.

Dosage

Ulunar Breezhaler-H-C-3875-PSUV-0002: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Strength

Ulunar Breezhaler-H-C-3875-PSUV-0002: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Pack Size

Ulunar Breezhaler-H-C-3875-PSUV-0002: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Form

Ulunar Breezhaler-H-C-3875-PSUV-0002: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Source

European Medicines Agency

View Source

Safety Profile

Contraindications

Ulunar Breezhaler-H-C-3875-PSUV-0002: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Side Effects

Ulunar Breezhaler-H-C-3875-PSUV-0002: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Related Clinical Articles

Scan this QR code to access this page quickly on your mobile device.

QR Code